GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N92020C00020MAXIM BIOMEDICAL, INC

Overview

Award facts

Net obligations
$5.25M
$5,253,450of $5.25M potential value
Outlays (paid to date)
$5.25M
$5.25M paid of $5.25M obligated$5,253,450
Period of performance
Aug 28, 2020 to Aug 27, 2023
Ended
Modifications
7
Latest action Mar 26, 2024
Contract type
Definitive contract
PIID 75N92020C00020

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

RADX TECH - MAXIM SARS-COV-2 ANTIGEN RAPID TEST

Dates and value

Award date
Signed on Aug 28, 2020
Potential end of performance
Aug 26, 2023
Current value
$5,253,450Base and exercised options
Potential value (if all options are exercised)
$5,253,450

Obligations by fiscal year of action

  • FY2021: $3,153,450
  • FY2020: $2,100,000

Total across 2 fiscal years: $5,253,450

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 26, 2024. View on USAspending · Recipient on SAM.gov

Recipient

LocationROCKVILLE, MD
UEIYV7LJS28ERK8
CAGE code4EJW3
Business sizeSmall businessSize at award, per the contracting officer
Parent companyMAXIM BIOMEDICAL, INC

Business types and certifications

Women-ownedWomen-owned small business (WOSB)Economically disadvantaged WOSB (EDWOSB)Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationLimited liability companyManufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NHLBI
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NHLBI
Funded from
National institute of biomedical imaging and bioengineering (0898)Program activities075-0898Federal accounts (agency financial reports)

Place of performance

Place of performance
Rockville, Montgomery County, Maryland 20850-0303
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Not competedC
Reason not competed
Urgency (FAR 6.302-2)URG
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Contract details

Subcontracting plan
Plan not requiredB
Major program
Rapid acceleration of diagnostics (RADX)
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 28, 2020Base obligation at award: $2,100,000
Latest action
Mar 26, 2024 — Other administrative actionModification P00007; administrative: no change in scope or value
Latest substantive action
Dec 2, 2021 — Supplemental agreement (within scope)Modification P00003
Actions by type
  • Base award1
  • Other administrative action4
  • Supplemental agreement (within scope)1
  • Letter contract definitized1
  • Closeout1
8 actions recorded, Aug 28, 2020 to Mar 26, 2024; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N920
Transactions recorded under this award key
8

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N920
Treasury accounts
  • 075-X-0898-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • P: Emergency P.L. 116-139
COVID-19 supplemental obligations
$5,253,450
COVID-19 supplemental outlays
$5,253,450